Impact of Graft-Versus-Host Disease (GVHD) Prophylaxis on 3-Year Disease-Free Survival (DFS): Results of a Multi-Center, Randomized Phase II-III Trial Comparing T Cell Depletion/Cyclosporine (TCD) and Methotrexate/Cyclosporine (M/C) in 410 Recipients of U

Go back to Resources

Impact of Graft-Versus-Host Disease (GVHD) Prophylaxis on 3-Year Disease-Free Survival (DFS): Results of a Multi-Center, Randomized Phase II-III Trial Comparing T Cell Depletion/Cyclosporine (TCD) and Methotrexate/Cyclosporine (M/C) in 410 Recipients of U

Authors:

Location:

Go back to Resources